Chronic Total Occlusion (CTO) occurs when a coronary artery is completely blocked, usually described as more than 99% stenosed, for a duration that is longer than three months. This results in a significant decrease in blood flow, causing coronary artery disease. If one or more of the coronary arteries are totally blocked, a heart attack may occur. The blocks are caused by build-up of plaque within the artery. The devices used to treat blocked arteries or chronic total occlusion are called chronic total occlusion devices. These devices enable health care providers to remove the block through a minimally invasive procedure. In the event of a coronary artery disease occurrence, chronic total occlusion is frequently identified as the toughest lesion to be remedied by percutaneous coronary intervention. Chronic total occlusion devices help arteries regain their normal function by removing blockages, resulting in improved heart function. They also aid in improving the patient's quality of life by enhancing ventricular function and diminishing symptomatic ischemia.
The global CTO devices market is expected to be driven by a surge in demand for minimally invasive surgical procedures. Improvements in medical finance alternatives, new product launches by major companies, and advanced technologies to improve upon existing devices are expected to favorably influence the CTO devices market in the next few years. Rise in number of patients afflicted with coronary artery disease and peripheral artery disease is expected to increase the use of chronic total occlusion devices globally. The procedures conducted by these devices have a slightly raised risk of damage to kidneys, bleeding at the site of puncture, damage to blood vessels, and marginal tears in the arteries’ inner lining. Certain factors need to be considered while selecting a device. These could include the length of the lesion, ratio of calcification, location of re-entry zones, and availability of a particular device in the facility where the treatment is being carried out. Chronic total occlusion is prevalent in around 30% of patients suffering from cardiovascular disease who undergo angiography.
The global CTO devices market can be segmented based on equipment, end-user, and region. In terms of equipment, the global CTO devices market can be classified into micro catheters, guide wires, crossing devices, re-entry devices, and others. The guide wires segment is expected to constitute a dominant share of the CTO devices market during the forecast period in terms of type. Based on end-user, the global CTO devices market can be segmented into hospitals, diagnostic centers, ambulatory care centers, and others. Advancement in crossing technologies has enabled health care providers in hospitals to intercept lesions or blockages with higher success ratios.
In terms of region, the global CTO devices market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to be a dominant region of the CTO devices market during the forecast period owing to innovations and improvement in techniques. Rise in investments in health care infrastructure in Asia Pacific is expected to positively influence the CTO devices market in the near future. In Europe, trials were successfully conducted to compare chronic total occlusion devices performance with optimized medical therapy. The trials showed an optimistic success rate and minimal procedural risk, which is estimated to increase the preference for chronic total occlusion devices in the next few years.
The key players operating in the global CTO devices market are Boston Scientific Corporation, Terumo Europe NV, Medtronic, Cardinal Health (Cordis), Spectranetics, BARD Peripheral Vascular, Baylis Medical, and Soundbite Medical Solutions.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.